CalciMedica, Inc.
CALC
$2.06
$0.063.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 9.73M | 8.92M | 8.79M | 9.19M | 9.52M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.20M | 22.35M | 21.45M | 21.50M | 21.88M |
| Operating Income | -24.20M | -22.35M | -21.45M | -21.50M | -21.88M |
| Income Before Tax | -13.70M | -13.59M | -12.59M | -14.94M | -34.36M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -13.70 | -13.59 | -12.59 | -14.94 | -34.36 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.70M | -13.59M | -12.59M | -14.94M | -34.36M |
| EBIT | -24.20M | -22.35M | -21.45M | -21.50M | -21.88M |
| EBITDA | -24.15M | -22.29M | -21.39M | -21.44M | -21.82M |
| EPS Basic | -1.18 | -1.57 | -1.88 | -2.64 | -26.09 |
| Normalized Basic EPS | -0.73 | -0.98 | -1.17 | -1.65 | -4.00 |
| EPS Diluted | -1.18 | -1.57 | -1.88 | -2.64 | -26.09 |
| Normalized Diluted EPS | -0.73 | -0.98 | -1.17 | -1.65 | -4.00 |
| Average Basic Shares Outstanding | 44.98M | 37.76M | 32.29M | 26.82M | 17.89M |
| Average Diluted Shares Outstanding | 45.27M | 38.05M | 32.58M | 27.12M | 17.89M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |